查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1604750

自動注射器市場：治療方法、產品類型、應用和最終用戶 - 2025-2030 年全球預測

Auto-Injectors Market by Therapy (Anaphylaxis, Diabetes, Multiple Sclerosis), Product Type (Disposable Auto-Injectors, Reusable Auto-Injectors), Application, End-user - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年自動注射器市值為673.9億美元，預計到2024年將達到806.2億美元，複合年成長率為19.72%，到2030年將達到2377億美元。

自動注射器市場包括設計用於自我給藥的設備，主要致力於緩解急性過敏反應和慢性疾病，例如類風濕性關節炎和多發性硬化症。這些設備對於提供準確的劑量、提高患者的依從性以及允許個人獨立管理自己的健康狀況至關重要。它應用於急診醫學、居家醫療和醫院等各個領域，最終用戶範圍從個別患者到大型醫療保健提供者。慢性病盛行率的上升、過敏事件的增加以及藥物輸送系統的技術進步正在推動市場的成長。此外，對生技藥品和生物相似藥的需求不斷成長，特別是在新興國家，帶來了利潤豐厚的機會。自動注射器增強的便攜性、易用性和安全機制吸引了患者和投資者的極大興趣。

主要市場統計
基準年[2023] 673.9億美元
預測年份 [2024] 806.2億美元
預測年份 [2030] 2377億美元
複合年成長率（%） 19.72%

然而，市場成長受到自動注射器價格高、監管障礙以及需要持續產品創新以滿足全球多樣化患者需求等因素的阻礙。另一個問題是自動注射器在尚未滲透的市場中的認知度較低。儘管存在這些障礙，遠端醫療和數位健康平台的擴展正在推動自動注射器的採用，並為製造商開闢了重要的成長途徑。為了挖掘市場潛力，公司應專注於整合物聯網等智慧技術，以提供劑量追蹤和連接等高級功能。研究應針對設備的小型化、提高劑量穩定性和更環保的設計，以解決環境問題。總體而言，自動注射器市場是一個由技術創新和以患者為中心的進步驅動的動態市場，但必須從策略上克服監管和成本挑戰才能實現永續成長。

市場動態：揭示快速發展的自動注射器市場的關鍵市場洞察

自動注射器市場正因供需的動態互動而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 人群過敏反應盛行率上升
    • 越來越傾向於自行注射
    • 透過網路藥局管道傳播
  • 市場限制因素
    • 自動注射器裝置的安全性和可用性問題
  • 市場機會
    • 改進自動注射器設計和技術
    • 擴大居家醫療服務
  • 市場問題
    • 嚴格的法規和核准要求

波特的五力：駕馭自動注射器市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架描述了評估公司競爭和探索策略機會的清晰方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點，避免潛在的挑戰，確保更強大的市場地位。

PESTLE分析：了解自動注射器市場的外部影響

外部宏觀環境因素在塑造自動注射器市場的績效動態發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析：了解自動注射器市場的競爭狀況

自動注射器市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、細分和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣：自動注射器市場供應商的績效評估

FPNV定位矩陣是評估自動注射器市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議：繪製自動注射器市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對汽車注射器市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭格局中的挑戰，利用新的商機並取得長期成功。

該報告對涵蓋關鍵焦點細分市場的市場進行了全面分析。

1. 市場滲透率：詳細檢視當前市場環境，主要企業的廣泛資料，評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有細分市場的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、主要產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策。

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品和地區提供最佳投資機會？

3.塑造市場的關鍵技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 人群過敏反應盛行率上升
      • 自我注射的趨勢日益成長
      • 透過網路藥局管道廣泛銷售
    • 抑制因素
      • 自動注射器裝置的安全性和可用性問題
    • 機會
      • 自動注射器設計和技術改進
      • 提高居家醫療服務普及率
    • 任務
      • 嚴格的法規和核准要求
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治
    • 經濟
    • 社會
    • 科技
    • 法律
    • 環境

第6章自動注射器市場療法

  • 介紹
  • 過敏反應
  • 糖尿病
  • 多發性硬化症
  • 類風濕性關節炎

第7章自動注射器市場：依產品類型

  • 介紹
  • 一次性自動注射器
  • 可重複使用的自動注射器
    • 天空
    • 預填充

第8章自動注射器市場：依應用分類

  • 介紹
  • 過敏反應
  • 貧血
  • 心血管疾病
  • 糖尿病
  • 偏頭痛
  • 多發性硬化症
  • 乾癬
  • 類風濕性關節炎

第 9 章 自動注射器市場：依最終使用者分類

  • 介紹
  • 門診手術中心
  • 居家醫療
  • 醫院/診所

第10章北美和南美自動注射器市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太自動注射器市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲自動注射器市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • AbbVie Inc.
  • Amgen Inc.
  • Antares Pharma, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Becton, Dickinson and Company
  • Biogen Inc.
  • Bristol-Myers Squibb Company
  • Eli Lilly and Company
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline PLC
  • Harro Hofliger Verpackungsmaschinen GmbH
  • Johnson & Johnson Services, Inc.
  • Medeca Pharma AB
  • Merck KGaA
  • Mylan NV by Viatris Inc.
  • NEMERA Group
  • Novartis AG
  • Pfizer, Inc.
  • Ravimed Sp. z oo
  • Recipharm AB
  • Sanofi SA
  • SHL Medical AG
  • Stevanato Group
  • Teva Pharmaceutical Industries Ltd.
Product Code: MRR-ED54C46E91DD

The Auto-Injectors Market was valued at USD 67.39 billion in 2023, expected to reach USD 80.62 billion in 2024, and is projected to grow at a CAGR of 19.72%, to USD 237.70 billion by 2030.

The auto-injectors market encompasses devices designed for self-administration of drugs, primarily focusing on alleviating acute allergic reactions and chronic conditions like rheumatoid arthritis or multiple sclerosis. These devices are essential for delivering precise dosages, enhancing patient compliance, and empowering individuals to manage their health conditions independently. They are applied across various sectors, including emergency care, home healthcare, and hospitals, with end-users ranging from individual patients to large healthcare providers. The rising prevalence of chronic ailments, increasing anaphylaxis incidents, and technological advances in drug delivery systems fuel market growth. Moreover, the growing demand for biologics and biosimilars, especially in emerging economies, offers lucrative opportunities. Enhanced portability, usability, and safety mechanisms in auto-injectors are attracting substantial interest from both patients and investors.

KEY MARKET STATISTICS
Base Year [2023] USD 67.39 billion
Estimated Year [2024] USD 80.62 billion
Forecast Year [2030] USD 237.70 billion
CAGR (%) 19.72%

However, market growth is impeded by factors such as the high cost of auto-injectors, regulatory hurdles, and the need for consistent product innovation to meet diverse patient needs globally. Additionally, the lack of awareness about auto-injectors in underpenetrated markets poses a challenge. Despite these obstacles, the expansion of telemedicine and digital health platforms facilitates the broader adoption of auto-injectors, presenting manufacturers with a significant growth avenue. To capitalize on market potential, companies should focus on integrating smart technologies, like IoT, to offer advanced features such as dosage tracking and connectivity. Research should target device miniaturization, improved medication stabilization, and eco-friendly designs to address environmental concerns. Overall, the auto-injector market is dynamic, driven by innovation and patient-centric advancements, but requires strategic navigation of regulatory landscapes and cost challenges to achieve sustainable growth.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Auto-Injectors Market

The Auto-Injectors Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalence of anaphylaxis among population
    • Growing inclination towards self-administration of injections
    • Widespread availability through online pharmacy channels
  • Market Restraints
    • Issues pertaining to the safety and usability of auto-injectors devices
  • Market Opportunities
    • Improvement in auto injector designs and technology
    • Increasing penetration of home-care health services
  • Market Challenges
    • Stringent regulatory and approval requirements

Porter's Five Forces: A Strategic Tool for Navigating the Auto-Injectors Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Auto-Injectors Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Auto-Injectors Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Auto-Injectors Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Auto-Injectors Market

A detailed market share analysis in the Auto-Injectors Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Auto-Injectors Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Auto-Injectors Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Auto-Injectors Market

A strategic analysis of the Auto-Injectors Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Auto-Injectors Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Amgen Inc., Antares Pharma, Inc., AstraZeneca PLC, Bayer AG, Becton, Dickinson and Company, Biogen Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche Ltd., GlaxoSmithKline PLC, Harro Hofliger Verpackungsmaschinen GmbH, Johnson & Johnson Services, Inc., Medeca Pharma AB, Merck KGaA, Mylan N.V. by Viatris Inc., NEMERA Group, Novartis AG, Pfizer, Inc., Ravimed Sp. z o.o., Recipharm AB, Sanofi S.A., SHL Medical AG, Stevanato Group, and Teva Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Auto-Injectors Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Therapy, market is studied across Anaphylaxis, Diabetes, Multiple Sclerosis, and Rheumatoid Arthritis.
  • Based on Product Type, market is studied across Disposable Auto-Injectors and Reusable Auto-Injectors. The Reusable Auto-Injectors is further studied across Empty and Prefilled.
  • Based on Application, market is studied across Anaphylaxis, Anemia, Cardiovascular Diseases, Diabetes, Migraines, Multiple Sclerosis, Psoriasis, and Rheumatoid Arthritis.
  • Based on End-user, market is studied across Ambulatory Surgical Centers, Homecare Settings, and Hospitals & Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalence of anaphylaxis among population
      • 5.1.1.2. Growing inclination towards self-administration of injections
      • 5.1.1.3. Widespread availability through online pharmacy channels
    • 5.1.2. Restraints
      • 5.1.2.1. Issues pertaining to the safety and usability of auto-injectors devices
    • 5.1.3. Opportunities
      • 5.1.3.1. Improvement in auto injector designs and technology
      • 5.1.3.2. Increasing penetration of home-care health services
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory and approval requirements
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Auto-Injectors Market, by Therapy

  • 6.1. Introduction
  • 6.2. Anaphylaxis
  • 6.3. Diabetes
  • 6.4. Multiple Sclerosis
  • 6.5. Rheumatoid Arthritis

7. Auto-Injectors Market, by Product Type

  • 7.1. Introduction
  • 7.2. Disposable Auto-Injectors
  • 7.3. Reusable Auto-Injectors
    • 7.3.1. Empty
    • 7.3.2. Prefilled

8. Auto-Injectors Market, by Application

  • 8.1. Introduction
  • 8.2. Anaphylaxis
  • 8.3. Anemia
  • 8.4. Cardiovascular Diseases
  • 8.5. Diabetes
  • 8.6. Migraines
  • 8.7. Multiple Sclerosis
  • 8.8. Psoriasis
  • 8.9. Rheumatoid Arthritis

9. Auto-Injectors Market, by End-user

  • 9.1. Introduction
  • 9.2. Ambulatory Surgical Centers
  • 9.3. Homecare Settings
  • 9.4. Hospitals & Clinics

10. Americas Auto-Injectors Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Auto-Injectors Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Auto-Injectors Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Amgen Inc.
  • 3. Antares Pharma, Inc.
  • 4. AstraZeneca PLC
  • 5. Bayer AG
  • 6. Becton, Dickinson and Company
  • 7. Biogen Inc.
  • 8. Bristol-Myers Squibb Company
  • 9. Eli Lilly and Company
  • 10. F. Hoffmann-La Roche Ltd.
  • 11. GlaxoSmithKline PLC
  • 12. Harro Hofliger Verpackungsmaschinen GmbH
  • 13. Johnson & Johnson Services, Inc.
  • 14. Medeca Pharma AB
  • 15. Merck KGaA
  • 16. Mylan N.V. by Viatris Inc.
  • 17. NEMERA Group
  • 18. Novartis AG
  • 19. Pfizer, Inc.
  • 20. Ravimed Sp. z o.o.
  • 21. Recipharm AB
  • 22. Sanofi S.A.
  • 23. SHL Medical AG
  • 24. Stevanato Group
  • 25. Teva Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. AUTO-INJECTORS MARKET RESEARCH PROCESS
  • FIGURE 2. AUTO-INJECTORS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. AUTO-INJECTORS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL AUTO-INJECTORS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. AUTO-INJECTORS MARKET DYNAMICS
  • TABLE 7. GLOBAL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DISPOSABLE AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL AUTO-INJECTORS MARKET SIZE, BY EMPTY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PREFILLED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANAPHYLAXIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL AUTO-INJECTORS MARKET SIZE, BY ANEMIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL AUTO-INJECTORS MARKET SIZE, BY CARDIOVASCULAR DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL AUTO-INJECTORS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MIGRAINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL AUTO-INJECTORS MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL AUTO-INJECTORS MARKET SIZE, BY PSORIASIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL AUTO-INJECTORS MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL AUTO-INJECTORS MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOMECARE SETTINGS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL AUTO-INJECTORS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 40. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 45. BRAZIL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 50. CANADA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 55. MEXICO AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES AUTO-INJECTORS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 72. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 77. CHINA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 82. INDIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 87. INDONESIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 92. JAPAN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 97. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 102. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 107. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 112. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 117. TAIWAN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 122. THAILAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 127. VIETNAM AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA AUTO-INJECTORS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 138. DENMARK AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 143. EGYPT AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 148. FINLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 153. FRANCE AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 158. GERMANY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 163. ISRAEL AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 168. ITALY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 173. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 178. NIGERIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 183. NORWAY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 188. POLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 193. QATAR AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 198. RUSSIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 203. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 208. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 213. SPAIN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 218. SWEDEN AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 223. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 228. TURKEY AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY THERAPY, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY REUSABLE AUTO-INJECTORS, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM AUTO-INJECTORS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 240. AUTO-INJECTORS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 241. AUTO-INJECTORS MARKET, FPNV POSITIONING MATRIX, 2023